These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22104200)

  • 1. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
    Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
    Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
    Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of protein expression signatures in gastric carcinomas using clustering analysis.
    Begnami MD; Fregnani JH; Brentani H; Torres C; Costa WL; Montagnini A; Nonogaki S; Soares FA
    J Gastroenterol Hepatol; 2012 Feb; 27(2):378-84. PubMed ID: 21777278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 expression in gastric cancer indicates a poor prognosis.
    Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
    J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
    Choi JH; Ahn MJ; Park CK; Han HX; Kwon SJ; Lee YY; Kim IS
    APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY
    Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer.
    Kim JH; Kim MK; Lee HE; Cho SJ; Cho YJ; Lee BL; Lee HS; Nam SY; Lee JS; Kim WH
    Mod Pathol; 2007 Aug; 20(8):835-42. PubMed ID: 17491598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer.
    Müller W; Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE
    Anticancer Res; 2000; 20(3A):1787-92. PubMed ID: 10928108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
    Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 as a prognostic marker in human gastric cancer.
    Jackson CB; Giraud AS
    J Gastroenterol Hepatol; 2009 Apr; 24(4):505-7. PubMed ID: 19368630
    [No Abstract]   [Full Text] [Related]  

  • 20. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
    Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
    Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.